Skip to main content

Table 5 Linear regression analyses of factors associated with SF-36 and EQ-5D-3 L scores in patients with systemic sclerosis

From: Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study

  SF-36 EQ-5D-3 L
Physical component score Mental component score  
Slope (SE) Beta P Slope (SE) Beta P Slope (SE) Beta P
Age − 0.06 (0.06) − 0.05 0.352 0.05 (0.10) 0.04 0.629 − 0.001 (0.002) − 0.06 0.430
Sex 0.44 (2.02) 0.01 0.829 1.83 (3.33) 0.05 0.583 0.039 (0.062) 0.04 0.534
BMI 0.32 (0.14) 0.13 0.022 − 0.17 (0.22) − 0.07 0.448 0.005 (0.004) 0.10 0.199
Disease duration − 0.08 (0.03) − 0.15 0.009 − 0.03 (0.05) − 0.06 0.516 − 0.002 (0.001) − 0.13 0.072
Subset (lcSSc) 4.13 (1.39) 0.16 0.004 4.34 (2.29) 0.17 0.061 0.090 (0.043) 0.15 0.039
mRSS − 0.25 (0.07) − 0.21 0.001 − 0.28 (0.12) − 0.24 0.021 − 0.005 (0.002) − 0.19 0.021
Raynaud’s VAS − 1.15 (0.95) − 0.08 0.229 − 2.40 (1.57) − 0.16 0.129 − 0.016 (0.029) 0.05 0.579
Digestive VAS − 3.69 (1.02) − 0.24 < 0.001 0.11 (1.69) 0.01 0.947 − 0.051 (0.031) − 0.14 0.105
Pulmonary VAS − 2.68 (0.90) − 0.19 0.004 − 0.04 (1.48) − 0.01 0.979 − 0.051 (0.028) − 0.15 0.066
Digital ulcer VAS − 0.68 (0.91) − 0.04 0.455 3.23 (1.50) 0.20 0.084 0.015 (0.028) 0.04 0.581
Disease severity VAS − 3.18 (1.04) − 0.22 0.003 − 3.18 (1.70) − 0.23 0.064 − 0.098 (0.032) − 0.30 0.003
  1. SF-36, Short Form (36) health survey; EQ-5D-3L, three-level version of the EuroQol Five-Dimensional descriptive system; BMI, body mass index; lcSSc, limited cutaneous systemic sclerosis; VAS, visual analogue scale; PAH, pulmonary arterial hypertension; ILD, interstitial lung disease